Find Academic Supervisors

Esther M SternbergView profile

Professor

• Mind-Body Medicine
• Environmental Health
• Stress and Wellness
• +3 more

Esther M Sternberg, MD, is a Professor of Medicine at the University of Arizona College of Medicine Tucson and holds joint appointments in Psychology, Architecture, Planning & Landscape Architecture. She serves as Director of Research at the Andrew Weil Center for Integrative Medicine and Founding Director of the Institute on Place, Wellbeing & Performance. Her research bridges mind-body medicine, environmental health, and stress physiology, emphasizing the interplay between physical environments, inflammation, and human wellbeing. Dr. Sternberg earned her MD and bachelor’s degree from McGill University (1972–1974), followed by residency and rheumatology fellowship at McGill. She spent 26 years at the NIH as a Senior Scientist and Section Chief of Neuroendocrine Immunology and Behavior. Her work has redefined understanding of stress-induced inflammation and the role of the built environment in health. Research Interests: Mind-body-stress-wellbeing interconnections Environmental design’s impact on health Inflammation in health disparities Neuroendocrine-immune pathways Integrative medicine frameworks Publications: Her work spans 50+ years, with recent focus on urban greenspace, workplace wellbeing, and biomarker-based stress assessment. Notable books include Healing Spaces and The Balance Within , which explore environmental and emotional influences on health. Awards: Anita Roberts NIH Distinguished Woman Scientist Lectureship U.S. HHS Superior Service Award Trinity College Honorary Doctorate NLM recognition for pioneering medicine Advocacy & Outreach: Advised WHO, US Surgeon General, and Vatican on stress and environment. Hosted PBS special The Science of Healing (2022). Active in policy initiatives promoting health-centered urban design and integrative medical practices. Labs & Teams: Leads interdisciplinary teams at the Institute on Place, Wellbeing & Performance, focusing on real-time health metrics, environmental design, and precision aging interventions.

• Clinical Nutrition
• Exercise Physiology
• Obesity Research
• +4 more

Tanya Halliday is an Assistant Professor in the Department of Health, Kinesiology, and Recreation at the University of Utah, with an adjunct appointment in Nutrition & Integrative Physiology. She holds a PhD in Clinical Physiology and Metabolism from Virginia Tech and is a Registered Dietitian (RD). Her research focuses on appetite regulation, exercise physiology, obesity, and weight management strategies. She has authored over 60 scholarly articles and contributed to evidence-based guidelines for medical nutrition therapy. Dr. Halliday also leads NIH-funded research on lifestyle interventions for weight loss maintenance and has received awards such as the Outstanding Recent Alumni from Virginia Tech and the Emerging Investigator Award from the Academy of Nutrition and Dietetics. She teaches courses in thesis research and trends in health, kinesiology, and recreation. Her work bridges clinical practice and research, emphasizing the role of diet and exercise in metabolic health and chronic disease prevention. Education: BS in Dietetics, University of Wyoming (2010) RD Dietetic Internship, University of Houston (2011) PhD in Human Nutrition, Virginia Tech (2016) NIH-funded Postdoctoral Fellowship in Endocrinology & Metabolism at University of Colorado Anschutz (2018) Research Interests: Dr. Halliday investigates how exercise modalities (aerobic vs. resistance) influence appetite, energy intake, and body weight regulation. Her work also explores sex-based biological variables in metabolic responses and develops adaptive interventions for weight loss maintenance. She examines the impact of lifestyle interventions on cardiometabolic health, including glycemic control and stress-sleep interactions during pandemics. Grants & Funding: NIH/National Center for Advancing Translational Sciences (KL2 award) Subcontract from University of Colorado for NIH R21 grant University of Utah’s Vice President’s Clinical and Translational Research Scholars Program Funding for projects on whey protein supplementation in athletes and time-of-day effects of resistance exercise Teaching: Dr. Halliday teaches advanced courses including thesis research supervision and trends in health and kinesiology. She mentors students in independent research projects and journal readings. Awards & Recognition: Outstanding Recent Alumni, Virginia Tech (2020) Vice President’s Clinical and Translational Research Scholar (2019) Emerging Investigator Award, Academy of Nutrition and Dietetics (2019) Top 10 Abstract Award, Obesity Society (2017) Labs & Collaborations: Her research is conducted within interdisciplinary teams at the University of Utah, focusing on translational studies in nutrition and exercise. Collaborations include the Anschutz Health and Wellness Center and the Nutrition Obesity Research Center at University of Colorado.

• Digital Health
• Biomedical Informatics
• Diabetes Management
• +4 more

Garrett Ash, PhD, is an Assistant Professor of Medicine (General Medicine) and Assistant Professor of Biomedical Informatics & Data Science at Yale University. He holds dual appointments in the Yale School of Medicine and the Department of Biomedical Informatics & Data Science. His research focuses on leveraging wearable biosensors and digital health technologies to personalize care for chronic conditions, particularly diabetes and sleep disorders. Dr. Ash completed his PhD in Exercise Physiology at the University of Connecticut and postdoctoral fellowships at Yale, specializing in data science under Mark Gerstein, PhD. He has been recognized with awards such as the Diabetes Special Interest Group Innovative Research Award (2024) and the Yale Innovation Summit ePoster Winner (2023). Education: PhD in Exercise Physiology (University of Connecticut, 2015), MSc in Science and Medicine of Athletic Performance (University of Oxford, 2009), BA in Chemistry (Swarthmore College, 2005). Research Interests: Digital health interventions, telemedicine workflows, continuous glucose monitoring, wearable device integration, and AI-driven health analytics. His work emphasizes translating real-time biometric data into actionable insights for patients and clinicians, particularly in diabetes management and behavioral health. Key Projects: Principal Investigator on an NIDDK-funded study developing an informatics-based digital application for safe exercise in adults with type 1 diabetes. Co-led a VA HSR&D pilot study on continuous glucose monitoring in veterans with type 2 diabetes. Collaborates on virtual reality interventions for adolescents with diabetes and AI-powered digital phenotyping for psychiatric disorders. Awards: Multiple accolades for innovative research in diabetes and digital health, including the 2023 Yale Innovation Summit award for merging exercise physiology, wearables, and behavioral health. Professional Roles: Senior Editor of Journal of Strength and Conditioning Research , Associate Editor of Journal of Clinical Hypertension , Scientific Committee member of the Sports Tech Research Network. Active in editorial and advisory roles across multiple journals and initiatives.

• Mental Health
• Post-Traumatic Stress Disorder (PTSD)
• Veteran Health
• +3 more

Ian Fischer is a Postdoctoral Research Fellow at the Yale School of Medicine. His research focuses on mental health outcomes among U.S. military veterans, particularly examining post-traumatic stress disorder (PTSD), resilience factors, and comorbid conditions such as chronic pain and insomnia. Fischer collaborates with institutions like the National Health and Resilience in Veterans Study to conduct large-scale epidemiological research, addressing issues such as suicide risk, firearm safety, and pandemic-related psychological impacts. Key areas of study include: PTSD diagnosis optimization using symptom clustering Psychosocial correlates of optimism and resilience Functional outcomes of mindfulness practices in veterans Longitudinal trends in veteran mental health during public health crises Recent work has explored: Genetic risk factors for depression in veterans Cross-cultural validation of resilience measurement tools Age-related stereotypes influencing health outcomes Sex-based differences in trauma responses Fischer's research integrates clinical psychiatry with population health approaches, producing over 35 peer-reviewed publications since 2016. His work has been featured in high-impact journals like World Journal of Biological Psychiatry and The Lancet Psychiatry, with findings influencing evidence-based interventions for veteran populations.

• Oral cancer
• Oral pathology
• Oral medicine
• +5 more

Associate Professor Omar Kujan is a leading academic at The University of Western Australia's Dental School, where he serves as Lead Discipline in Oral Pathology, Head of the Oral Diagnostic and Surgical Sciences Division, and leads the Oral and Maxillofacial Biology and Diseases Research Stream. AHPRA-registered oral and maxillofacial pathology specialist, he holds fellowships from the Royal College of Pathologists (UK and Australasia) and maintains active clinical and research roles at the Oral Health Centre. His educational background includes a PhD from the University of Manchester School of Dentistry (2006), followed by clinical training at Guy's Hospital, King's College London. He joined UWA in 2016 after significant contributions to the WHO Collaborating Centre for Oral Cancer, where his binary oral epithelial dysplasia grading system was adopted in the WHO Head and Neck Tumours classification. Dr. Kujan's research focuses on critical areas in oral oncology including biomarker discovery for early oral cancer detection, risk stratification of oral potentially malignant disorders, molecular mechanisms of oral carcinogenesis, and chemopreventive strategies. His work directly addresses UN Sustainable Development Goals related to good health and well-being through advancements in early cancer detection and prevention. His recent publications reveal a strong emphasis on systematic reviews of biomarker validity (particularly chemokines in oral cancer), diagnostic methodology refinement, and global epidemiological studies of oral diseases. This reflects his commitment to evidence-based practice and international standardization in oral pathology diagnosis. Dental School Award for Research Mentorship (2024) Dental School Senior Research Award (2024) Dental School Award in Research Impact and Innovation (2022) Australia’s research field leader in Oral & Maxillofacial Surgery (2020) Stanford University's top 2% scientists list (2022-2024) As Graduate Research Coordinator, he supervises 8 PhD students while securing competitive grants including NHMRC Ideas grants and Australian Dental Research Foundation projects totaling over $13,000. His editorial leadership as Associate Editor for Journal of Oral Pathology and Medicine, Frontiers in Oncology, Scientific Reports, and Frontiers in Oral Health demonstrates his influence in shaping oral cancer research discourse. The Oral and Maxillofacial Biology and Diseases Research Stream under his direction integrates molecular pathology, clinical diagnostics, and translational research to address oral cancer challenges.

Nathaniel MarshallView profile

Professor

• Sleep Medicine
• Epidemiology
• Clinical Trials
• +3 more

Nathaniel Marshall is a Professor in the Department of Health Sciences at Macquarie University and affiliated with the Woolcock Institute for Medical Research. Specialising in sleep medicine and epidemiology, he focuses on clinical trials and population-based cohorts such as the Busselton Health Study. His research addresses sleep disorder impacts, treatment efficacy, and health system activities related to sleep. He holds editorial roles in journals like SLEEP and serves on committees for organizations including the Australasian Sleep Association. Marshall has received notable awards such as the American Academy of Sleep Medicine Fellowship and the Excellence in Research: MCR prize (2023). Education: PhD in Public Health (Massey University), PGDipHealSc (University of Otago), BCom and BSc in Psychology (University of Otago). External roles: Deputy Chair of Australasian Sleep Association Finance Committee, Editorial Board member of European Respiratory Society, and Associate Editor of SLEEP . Research Interests: Sleep epidemiology, clinical trials for sleep disorders, obstructive sleep apnea interventions, and health policy implications. His work spans cannabinoid therapies, melatonin treatments for Parkinson’s-related sleep disorders, and the health effects of environmental factors like wind turbine infrasound. Recent Projects: Includes randomized trials on schizophrenia screening for sleep apnea, mobile app-based sleep therapy for chronic pain, and investigating wind turbine infrasound impacts. Awards: Highlighted achievements include Top Reviewer distinctions in medicine and chest journals, reflecting his peer-review contributions. Grants & Advising: Leads projects funded by MRFF (2023) and collaborates on initiatives like the SleepBack study. Advises clinicians and researchers through the Investigator Initiated Research Clinic. Labs/Teams: Active in the Woolcock Institute’s sleep research and collaborates across disciplines in health sciences and medicine.

Anka VujanovicView profile

Professor

• Posttraumatic Stress Disorder (PTSD)
• Substance Use Disorders
• Suicide Risk
• +3 more

Dr. Anka Vujanovic is a Professor in the Department of Psychological and Brain Sciences at Texas A&M University and holds a joint appointment in the Department of Psychiatry and Behavioral Sciences at the Texas A&M School of Medicine. She directs the Trauma and Stress Studies Center and the First Responder Consortium, and is a Research Professor at the University of Houston's Department of Psychology. With a Ph.D. from the University of Vermont and clinical training from Brown University, her research focuses on PTSD, substance use disorders (SUD), suicide risk, and trauma interventions, particularly among first responders, military veterans, and survivors of human trafficking. Her work integrates longitudinal studies, clinical trials, and ecological momentary assessment to develop evidence-based treatments. She has authored over 250 publications and secures funding from NIH and private foundations. Dr. Vujanovic leads editorial roles in journals including Cognitive Behaviour Therapy and Mindfulness . Her research emphasizes transdiagnostic approaches, including mindfulness-based interventions for firefighters and culturally adapted treatments for global trauma survivors. Key affiliations include Texas A&M’s clinical training programs and the First Responder Consortium. Her grants support projects on telemental health for trafficking survivors and trauma-focused cognitive-behavioral therapies. Current initiatives explore firearm safety among emergency personnel and resilience-building programs for high-risk populations.

Bianca D'AntonoView profile

Professor

• Cardiovascular Psychology
• Behavioral Medicine
• Psychophysiology
• +5 more

Bianca D'Antono is a Full Professor at the Department of Psychology, Faculty of Arts and Sciences, University of Montreal, and Director of the Hearts and Souls Research Unit in Behavioral and Complementary Medicine at the Montreal Heart Institute (ICM). Her research explores mind-body interactions in cardiovascular disease, focusing on psychological and psychophysiological determinants. University of Montreal - Full Professor, Department of Psychology Montreal Heart Institute (ICM) - Director of Behavioral & Complementary Medicine Research Unit Key methodologies: Experimental studies, physiological monitoring, ecological data validation Research Interests: The Hearts and Souls laboratory investigates: Psychological distress mechanisms in cardiovascular patients Gender differences in stress response and autonomic function Stress-induced inflammatory pathways Mindfulness-based interventions for coronary risk Psychosomatic effects of childhood maltreatment Article Trends: Recent publications demonstrate expertise in: Mind-body interactions in chronic illness Stress response biomarkers Gender-specific cardiovascular psychopathology Digital health interventions Psychosocial predictors of disease progression Scientific Awards: Top 10% reviewer - Annals of Internal Medicine Lucien Campeau Prize (2011) Meritorious Student Award (2013) FRSQ Junior Research Fellow (2007-2012) Supervision: Directed 10+ theses since 2015 including Alexandra Connor (PhD 2024), Ann Xiuli Chicoine (MSc 2024), and Vicki St-Arnaud (MSc 2023).

• Child Advocacy
• Community Medicine
• Developmental Pediatrics
• +4 more

Leslie Sude, MD, is an Associate Professor of Pediatrics at Yale School of Medicine and holds leadership roles as Associate Medical Director of the Pediatric Primary Care Center and Medical Director of the Community Health Care Van Mother Infant Program. Her work focuses on improving health equity for low-income families through initiatives like mobile healthcare clinics and financial wellness programs. She completed her MD at Medical College of Pennsylvania (1988), residency at University of Michigan Medical Center (1991), and earned a BA in Philosophy of Religion from Bryn Mawr College (1984). Her research emphasizes child advocacy, developmental and behavioral pediatrics, and community medicine. Notable projects include establishing the first co-located Volunteer Income Tax Assistance site in a medical clinic (2017) and expanding post-partum maternal and newborn health checks via mobile clinics during the pandemic (2020). Dr. Sude’s publications address financial health integration in healthcare, mobile medical innovations, and sleep health disparities. She collaborates with interdisciplinary teams on initiatives like the New Haven Nature and Health consortium, promoting nature-based health interventions.

• Neuroscience
• Psychiatry
• Neuroimaging
• +7 more

Dr. Jose Cortes-Briones is an Assistant Professor in the Department of Psychiatry at Yale University, serving as Technical Director of the MEG Imaging for Neuropsychiatric Disorders (MIND) Center at the West Haven VA Healthcare System. He is also a member of the Schizophrenia Neuropharmacology Research Group (SNRGY) and the Yale Center for the Science of Cannabis and Cannabinoids (YC-SCAN2). His research focuses on understanding brain dynamics influenced by psychoactive substances like THC and ketamine, auditory verbal hallucinations in schizophrenia, and applying machine learning to neuroimaging data. Key areas include reconstructing fetal EEG from maternal signals, MEG studies of THC effects, and excitatory/inhibitory balance in psychiatric disorders. Research Interests: Cannabis and ketamine neuropharmacology Magnetoencephalography (MEG) and EEG analysis Machine learning in neuroimaging Schizophrenia biomarkers Clinical high-risk psychosis Dr. Cortes-Briones has received prestigious awards including the 2024 Blavatnik Award and YNHHS Innovation Award. His work spans clinical trials such as the M1 Schizophrenia PET Study and longitudinal studies on cannabis neurodevelopmental effects. Collaborations include work with Deepak Dsouza, Marc Normandin, and Mohini Ranganathan on cannabinoid receptor studies and psychotomimetic effects. His articles highlight breakthroughs in detecting neural oscillations, developing AI-based sleep spindle detectors, and investigating THC's role in cortical noise. Ongoing efforts focus on translating findings into clinical tools for mental health diagnosis and treatment.

• Posttraumatic Stress Disorder (PTSD)
• Clinical Psychology
• Sleep Disorders
• +4 more

Jason DeViva is an Associate Professor of Psychiatry at Yale School of Medicine and works with the VA Connecticut Health Care System. He co-directs the PTSD Clinical Team and serves as a PTSD mentor for the VA New England region. His roles include military sexual trauma coordinator for VA Connecticut and national lead trainer for cognitive-behavioral therapy for insomnia dissemination. He has 19 years of VA experience treating veterans with PTSD and anxiety disorders, publishing extensively on PTSD treatment engagement, sleep disturbances in PTSD, and insomnia therapies. He co-authored an award-winning book for families of individuals with PTSD. Education: PhD in Psychology, University of Hawaii (2001) Pre-doctoral Internship, Battle Creek VA Medical Center (2001) Postdoctoral Fellowship, Dartmouth Medical School (2003) Research Interests: Dr. DeViva focuses on improving engagement and completion rates of evidence-based PTSD treatments for veterans, exploring how sleep disturbances (e.g., insomnia) intersect with PTSD. He investigates bidirectional effects of treating PTSD and sleep disorders, emphasizing clinical outcomes and healthcare system implementation. Recent work examines opioid use disorder treatment modalities, military sexual trauma documentation, and integrating spiritual care in inpatient psychiatric settings. Grants & Collaborations: Collaborates with researchers like Allison Gaffey, Anne Klee, and Cynthia Brandt on VA-funded projects. His work is supported through VA clinical and research programs, though specific grant details are not listed here. Labs/Teams: Leads the PTSD Clinical Team at VA Connecticut and contributes to national VA initiatives like cognitive processing therapy dissemination.

• Psychiatric Neuroscience
• Neurobiology of Mental Disorders
• Medical Education
• +3 more

David Ross, MD, PhD is an Associate Professor Adjunct in the Department of Psychiatry at the Yale School of Medicine, Yale University. He holds academic appointments in Psychiatry and is affiliated with the National Neuroscience Curriculum Initiative (NNCI), serving as its Executive Director. His education includes an MD and PhD from Yale University, reflecting a strong foundation in both clinical practice and research. Dr. Ross’s research focuses on psychiatric neuroscience, neurobiology of mental disorders, and medical education innovation. He explores topics such as neuroplasticity, health disparities, and the integration of neuroscience into clinical practice. His work emphasizes addressing stigma around substance use disorders and improving communication of scientific concepts for mental health providers. His recent publications highlight interdisciplinary approaches, including studies on hippocampal neurogenesis, sex differences in traumatic brain injury, and the impact of solitary confinement on neurobiology. He has also contributed to community-based interventions targeting opioid stigma and developed online curricula for neuroscience education in psychiatry. Grants & Awards: 2021 Deeda Blair Research Initiative Grant for advancing neuroscience literacy in mental health education. Professional Contributions: Leadership in the NNCI to modernize psychiatric education and promote precision medicine through genetics curricula. Collaborations: Works with researchers like Ayala Danzig, Larry Marks, and Elyse Kyzar on topics ranging from neurodegeneration to health equity.

• Traumatic Brain Injury (TBI)
• Neuropsychology
• Rehabilitation
• +7 more

Professor Jennie Ponsford is the Director of the Monash-Epworth Rehabilitation Research Centre (MERRC) and Theme Lead of the Brain Injury Rehabilitation theme at the Turner Institute for Brain and Mental Health, Monash University. She is also Director of Clinical Programs and convenes the doctoral training program in clinical neuropsychology. Education: PhD in Clinical Neuropsychology (La Trobe University), BA Hons (University of Melbourne), MA in Clinical Neuropsychology (University of Melbourne) External Appointments: Dirk Bakker Visiting Professor (University of Maastricht, 2020-2022), Visiting Professor (Sunnaas Hospital, Oslo, 2015-present), Professor of Neuropsychology (Epworth HealthCare) Research Interests focus on traumatic brain injury (TBI) rehabilitation, cognitive deficits, sleep disturbance, fatigue, psychiatric outcomes, and telehealth interventions. She pioneered international studies on TBI comorbidities, cultural influences on recovery, and community-based rehabilitation models. Scientific Awards include the Robert L. Moody Prize (2013), Officer of the Order of Australia (2017), Australian Psychological Society awards (2018-2019), and the Dirk Bakker Visiting Professorship (2020). She was recognized as Australia's most cited scientist in rehabilitation therapy (2020). Teaching and Supervision includes Monash postgraduate courses in neuropsychology and clinical practice, along with non-HDR supervisions for students like Hannah Perry and Lucas Thoma. Her work aligns with UN SDGs for health and well-being.

Paul SalamhView profile

Visiting Associate Professor

• Frozen Shoulder
• Orthopedic Shoulder Conditions
• Overhead Athletes
• +5 more

Paul Salamh serves as a Visiting Associate Professor in the Department of Rehabilitation Sciences at Tufts University School of Medicine. His academic appointments include teaching responsibilities for courses such as Professional Expectations and Capstone at Tufts University. Education includes: Doctor of Physical Therapy, Duke University (2007) Doctor of Philosophy, Nova Southeastern University Bachelor of Science in Health Science, Lock Haven University Dr. Salamh's research program centers on orthopedic and sports rehabilitation, with concentrated expertise in: Frozen shoulder etiology and management Biomechanical risk factors in overhead athletes Ramadan fasting effects on athletic performance Clinical guidelines for shoulder pathologies Strength and conditioning paradigms His work integrates clinical practice with systematic evidence synthesis to advance rehabilitation methodologies. Recent scholarly publications (66 total) demonstrate consistent focus on sports medicine interventions, particularly shoulder injury mechanisms and management strategies. Trends from 2022-2025 research include systematic reviews of frozen shoulder treatments, COVID-19 impacts on athletic training, evidence-based guideline development, and innovative assessments of muscle function and athletic workloads.

• Mental health equity
• Digital interventions
• Stigma reduction
• +3 more

Dr. Frances J. Griffith is a Postdoctoral Fellow in the NIDA T32 program through Yale School of Medicine's Department of Psychiatry, Division of Prevention and Community Research. As a registered board-certified art therapist and clinical-community psychologist, she develops interventions for marginalized populations in recovery. Her research examines three primary areas: peer-led healthcare programs, multi-level stigma reduction strategies, and scalable digital/art-based interventions for mental health and substance use. Current projects employ innovative methods including social media analysis, NLP of intervention feedback, and RCT designs for art-based interventions. Recent publications demonstrate expertise in digital health evaluation, online community support mechanisms, and arts-based therapeutic approaches. Her work consistently focuses on health equity for populations with intersecting marginalized identities.